Clinically, I specialize in two areas: 1) morphology-based diagnosis of gastrointestinal and hepatobiliary diseases, and 2) molecular characterization of all types of cancer. In my day-to-day work, I collaborate with surgeons and oncologists to establish optimal diagnoses and management plans tailored to individual patients.
My research interest is, broadly, the molecular characterization of gastrointestinal tumors. My current and past work focuses on the prognostic, predictive, microscopic, molecular, and physiologic trends of molecular alterations in gastrointestinal malignancies, with special focus on actionable alterations. I am also interested in novel mechanisms of primary and secondary resistance to targeted therapies.
- Clinical Expertise: Molecular and Gastrointestinal Pathology
- Languages Spoken: English
- Education: MD, University of Miami
- Residencies: Mount Sinai Hospital (New York)
- Fellowships: Mount Sinai Hospital (New York); Memorial Sloan Kettering Cancer Center
- Board Certifications: Anatomic Pathology; Molecular Genetic Pathology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more